Medonic M16C-US, Руководство пользователя

Страница: 7 / 109

6
1.2 Safety Instruction
Description Boule incorporates safety features within the instrument in order to protect the
operator from injury, the instrument from damage and the test results from
inaccuracies.
Restrictions In order to insure the safety of the operator and instrument follow the
instruction below:

Do not use the instrument outdoors.

Do no modify the instrument.

Do not remove the cover. (Authorized personnel only)

Do not use the instrument for other purposes than described in this manual.

Do not spill blood or other fluids on the instrument in such a way that it can
leak through the instrument casing. (This might result in electrical
malfunction or personal injury)

Do not drop or place objects on the analyzer.

Do not use this device in close proximity to source of strong electromagnetic
radiation (e.g. unshielded international RF sources), as these can interfere
with the proper operation.

Do not use power supply other than supplied by your local distributor.
Important

Unauthorized modification of the instrument might result in erroneous
results or risk for electrical shock.

Spilling fluids into the instrument might cause electrical malfunction and/or
personal injury.
Handling of
reagents

If a reagent comes in contact with eyes, rinse with running water for several
minutes. If symptoms occur seek medical attention.

If the reagent comes into contact with skin, wash affected area with water.

If swallowed, rinse out mouth. If persistent symptoms occur seek medical
attention.

Refer to MSDS at www.cdsolinc.com for further details.

SDS Sheets are available for all reagents.
1.3 Biohazards
Description
As there are no assurances of the absence of HIV, Hepatitis B or C viruses or
other infectious agents in blood samples, controls, calibrators and waste these
products should be handled as potentially biohazardous.
Support
documentation

Protection of Laboratory Workers From Infectious Disease Transmitted by
occupationally acquired infections – 2
nd
Edition, Approved Guidelines
(2001) Document M29-T2 promulgated by the Clinical and Laboratory
Standards Institute, CLSI (NCCLS).

Follow local regulatory documentation.